WELL Health Q3-2026 adjusted EBITDA falls 15% year over year to $50.9 million

• WELL Health’s Q3-2026 adjusted net income fell 33% year-over-year to $27.3 million.
• Adjusted EBITDA dropped 15% year-over-year to $50.9 million, reflecting prior-year Circle Medical deferred revenue recognition.
• Canadian Patient Services adjusted EBITDA climbed 82% year-over-year to $25.7 million, reaching its $100 million annualized run-rate target one quarter early.
• WELLSTAR began trading on the TSX Venture Exchange October 1, separating healthcare technology operations from clinic operations.
• Full-year 2026 adjusted EBITDA guidance remained $185 million to $195 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WELL Health Technologies Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611091600NEWSFILECNPR____20261109_323185_1) on November 09, 2026, and is solely responsible for the information contained therein.